Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Window of Opportunity Study of Imatinib in Combination With Cetuximab in Patients With Squamous Cell Carcinomas of the Head and Neck

NCT05816785 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT05816785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05816785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Window of Opportunity Study of Imatinib in Combination With Cetuximab in Patients With Squamous Cell Carcinomas of the Head and Neck
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 1
Overall status
Completed
Start date
April 18, 2023
Completion date
August 8, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, squamous cell carcinoma of head and neck